Compromising Patient Protections to Lower Drug Costs Could Harm People with Cancer

November 27, 2018 – “While ASCO supports efforts to control drug prices, we are keenly aware that optimal cancer care requires patient access to the most medically appropriate drug, at the most opportune time, based on the highest quality evidence. Therefore, ASCO has significant concerns about the Centers for Medicare & Medicaid Services’ (CMS) proposed rule to reduce the number of prescription drugs that must be made available to Medicare beneficiaries … (leggi tutto)